|
1
|
King TE: Update in pulmonary medicine. Ann
Intern Med. 129:806–812. 1998. View Article : Google Scholar
|
|
2
|
Wolters PJ, Collard HR and Jones KD:
Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol.
9:157–179. 2013. View Article : Google Scholar
|
|
3
|
Raghu G, Freudenberger TD, Yang S, et al:
High prevalence of abnormal acid gastro-oesophageal reflux in
idiopathic pulmonary fibrosis. Eur Respir J. 27:136–142. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang LS, Berdyshev E, Mathew B, et al:
Targeting sphingosine kinase 1 attenuates bleomycin-induced
pulmonary fibrosis. FASEB J. 27:1749–1760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marks JH: Update in pulmonary medicine.
Adolesc Med State Art Rev. 24:307–329. xvi2013.PubMed/NCBI
|
|
6
|
Wynn TA: Integrating mechanisms of
pulmonary fibrosis. J Exp Med. 208:1339–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tager AM, LaCamera P, Shea BS, et al: The
lysophosphatidic acid receptor LPA1 links pulmonary
fibrosis to lung injury by mediating fibroblast recruitment and
vascular leak. Nat Med. 14:45–54. 2008.
|
|
8
|
Funke M, Zhao ZW, Xu Y, Chun J and Tager
AM: The lysophosphatidic acid receptor LPA1 promotes epithelial
cell apoptosis after lung injury. Am J Resp Cell Mol. 46:355–364.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang LS, Fu P, Patel P, et al:
Lysophosphatidic acid receptor-2 deficiency confers protection
against bleomycin-induced lung injury and fibrosis in mice. Am J
Respir Cell Mol Biol. 49:912–922. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Konigshoff M, Balsara N, Pfaff EM, et al:
Functional Wnt signaling is increased in idiopathic pulmonary
fibrosis. PLoS One. 3:e21422008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo Y, Xiao L, Sun L and Liu F:
Wnt/β-catenin signaling: a promising new target for fibrosis
diseases. Physiol Res. 61:337–346. 2012.
|
|
12
|
Lam AP, Flozak AS, Russell S, et al:
Nuclear β-catenin is increased in systemic sclerosis pulmonary
fibrosis and promotes lung fibroblast migration and proliferation.
Am J Respir Cell Mol Biol. 45:915–922. 2011.
|
|
13
|
Konigshoff M, Kramer M, Balsara N, et al:
WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in
mice and is upregulated in humans with idiopathic pulmonary
fibrosis. J Clin Invest. 119:772–787. 2009.PubMed/NCBI
|
|
14
|
Hosper NA, van den Berg PP, de Rond S, et
al: Epithelial-to-mesenchymal transition in fibrosis: collagen type
I expression is highly upregulated after EMT, but does not
contribute to collagen deposition. Exp Cell Res. 319:3000–3009.
2013. View Article : Google Scholar
|
|
15
|
Clarke DL, Carruthers AM, Mustelin T and
Murray LA: Matrix regulation of idiopathic pulmonary fibrosis: the
role of enzymes. Fibrogenesis Tissue Repair. 6:202013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KK, Wei Y, Szekeres C, et al:
Epithelial cell α3β1 integrin links β-catenin and Smad signaling to
promote myofibroblast formation and pulmonary fibrosis. J Clin
Invest. 119:213–224. 2009.
|
|
17
|
Milosevic J, Pandit K, Magister M, et al:
Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell
Mol Biol. 47:879–887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caraci F, Gili E, Calafiore M, et al:
TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in
the transition of human lung fibroblasts into myofibroblasts.
Pharmacol Res. 57:274–282. 2008.
|
|
19
|
Liu AR, Liu L, Chen S, et al: Activation
of canonical wnt pathway promotes differentiation of mouse bone
marrow-derived MSCs into type II alveolar epithelial cells, confers
resistance to oxidative stress, and promotes their migration to
injured lung tissue in vitro. J Cell Physiol. 228:1270–1283. 2013.
View Article : Google Scholar
|
|
20
|
Xia H, Seeman J, Hong J, et al: Low
α2β1 integrin function enhances the
proliferation of fibroblasts from patients with idiopathic
pulmonary fibrosis by activation of the β-catenin pathway. Am J
Pathol. 181:222–233. 2012.
|
|
21
|
Kono Y, Nishiuma T, Nishimura Y, et al:
Sphingosine kinase 1 regulates differentiation of human and mouse
lung fibroblasts mediated by TGF-β1. Am J Respir Cell Mol Biol.
37:395–404. 2007.PubMed/NCBI
|
|
22
|
Chen L, Ruan Y, Wang X, et al: BAY
11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S
phase arrest in gastric cancer cells. J Gastroenterol. 49:864–874.
2014.
|
|
23
|
Huang LS, Kim MR and Sok DE: Enzymatic
reduction of polyunsaturated lysophosphatidylcholine hydroperoxides
by glutathione peroxidase-1. Eur J Lipid Sci Tech. 111:584–592.
2009. View Article : Google Scholar
|
|
24
|
Huang LS, Kim MR and Sok DE: Oxygenation
of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases;
conjugated hydroperoxydiene and dihydroxytriene derivatives.
Lipids. 42:981–990. 2007. View Article : Google Scholar
|
|
25
|
Rancoule C, Pradere JP, Gonzalez J, et al:
Lysophosphatidic acid-1-receptor targeting agents for fibrosis.
Expert Opin Investig Drugs. 20:657–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scheraga RG and Thannickal VJ:
Wnt/β-catenin and transforming growth factor-β signaling in
pulmonary fibrosis. A case for antagonistic pleiotropy? Am J Respir
Crit Care Med. 190:129–131. 2014.
|
|
27
|
Chilosi M, Poletti V, Zamo A, et al:
Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary
fibrosis. Am J Pathol. 162:1495–1502. 2003.
|
|
28
|
Villar J, Cabrera NE, Valladares F, et al:
Activation of the Wnt/β-catenin signaling pathway by mechanical
ventilation is associated with ventilator-induced pulmonary
fibrosis in healthy lungs. PLoS One. 6:e239142011.
|
|
29
|
Kim TH, Kim SH, Seo JY, et al: Blockade of
the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary
fibrosis. Tohoku J Exp Med. 223:45–54. 2011.
|
|
30
|
Henderson WR Jr, Chi EY, Ye X, et al:
Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling
reverses pulmonary fibrosis. Proc Natl Acad Sci USA.
107:14309–14314. 2010.
|
|
31
|
Huang LS, Hung ND, Sok DE and Kim MR:
Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1
position is anti-inflammatory. Lipids. 45:225–236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang LS, Kim MR and Sok DE: Regulation of
lipoxygenase activity by polyunsaturated lysophosphatidylcholines
or their oxygenation derivatives. J Agric Food Chem. 56:7808–7814.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang LS, Kang JS, Kim MR and Sok DE:
Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from
soybean, porcine leukocyte, or rabbit reticulocyte. J Agric Food
Chem. 56:1224–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang LS, Kim MR, Jeong TS and Sok DE:
Linoleoyl lysophosphatidic acid and linoleoyl
lysophosphatidylcholine are efficient substrates for mammalian
lipoxygenases. Biochim Biophys Acta. 1770:1062–1070. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang LS, Kim MR and Sok DE: Linoleoyl
lysophosphatidylcholine is an efficient substrate for soybean
lipoxygenase-1. Arch Biochem Biophys. 455:119–126. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Milara J, Navarro R, Juan G, et al:
Sphingosine-1-phosphate is increased in patients with idiopathic
pulmonary fibrosis and mediates epithelial to mesenchymal
transition. Thorax. 67:147–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
